What is NDC 0093-5985?

0093-5985 is the product NDC for Epinephrine, Epinephrine .15 mg/.3mL injection, listed with the FDA by Teva Pharmaceuticals USA, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.

Teva Pharmaceuticals USA, Inc., NDC labeler code 0093. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Epinephrine?

75 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Yes: J0171, Injection, adrenalin, epinephrine, 0.1 mg.

Epinephrine NDC 0093-5985 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)0093-5985Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00093-5985Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0093-5985-27	0009359852700093598527	2 CONTAINER in 1 CARTON (0093-5985-27) / 1 SYRINGE in 1 CONTAINER (0093-5985-19) / .3 mL in 1 SYRINGEMarketed from Aug 19, 2019

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Epinephrine
Generic name (nonproprietary): epinephrine
Active ingredients: Epinephrine — .15 mg/.3mL
Dosage form: Injection
Route: Intramuscular, Subcutaneous
Labeler: Teva Pharmaceuticals USA, Inc.NDC labeler code 0093
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 090589
Marketing start: Aug 19, 2019
Listing expires: Dec 31, 2027
Other FDA classes: Adrenergic alpha-Agonists (Mechanism)Adrenergic beta-Agonists (Mechanism)Catecholamines (Chemical structure)
Identifiers: Product ID 0093-5985_f96bd477-2239-4453-aaa4-e20d16c6e49eSPL ID f96bd477-2239-4453-aaa4-e20d16c6e49eSPL set ID 04f07f15-55e2-411b-abb8-07eab37f5664RxCUI 727316, 1870207UNII YKH834O4BHUPC 0300935985275, 0300935986272
Pharmacologic class: Catecholamine; alpha-Adrenergic Agonist; beta-Adrenergic Agonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeMed-Code curated

J0171 — Injection, adrenalin, epinephrine, 0.1 mg

Billing unit: 0.1 mg. Units on the claim = dose given ÷ 0.1 mg.

Applies when epinephrine is administered in a clinical setting. Auto-injectors dispensed to patients are billed by NDC through a pharmacy benefit.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N400093598527 followed by a unit qualifier and the quantity

Package 00093-5985-27. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 31, 2021.

Indications (excerpt from the label)

Epinephrine Injection, 0.3 mg and Epinephrine Injection, 0.15 mg are indicated in the emergency treatment of allergic reactions (Type I) including anaphylaxis to stinging insects (e.g., order Hymenoptera, which include bees, wasps, hornets, yellow jackets and fire ants) and biting insects (e.g., triatoma, mosquitoes), allergen immunotherapy, foods, drugs, diagnostic testing substances (e.g., radiocontrast media) and other allergens, as well as idiopathic anaphylaxis or exercise-induced anaphylaxis. Epinephrine Injection, 0.3 mg and Epinephrine Injection, 0.15 mg are intended for immediate administration in patients who are determined to be at increased risk for anaphylaxis, including individ…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 0093-5985

What is NDC 0093-5985?: 0093-5985 is the product NDC for Epinephrine, Epinephrine .15 mg/.3mL injection, listed with the FDA by Teva Pharmaceuticals USA, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Epinephrine.
What is the active ingredient?: Epinephrine.
Who is the labeler?: Teva Pharmaceuticals USA, Inc., NDC labeler code 0093. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Epinephrine?: 75 other product NDCs are listed under this name. See all Epinephrine NDCs.
Is there a related HCPCS / J-code?: Yes: J0171, Injection, adrenalin, epinephrine, 0.1 mg. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Epinephrine NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
epinephrine	Epinephrine 1 mg/mL	InjectionIntramuscular, Intravenous, Subcutaneous	Gland Pharma Limited	68083-699	68083-0699-1068083-0699-25
Epinephrine	Epinephrine 1 mg/mL	InjectionIntramuscular, Intravenous, Subcutaneous	Hikma Pharmaceuticals USA Inc.	0143-9476	00143-9476-25
Epinephrine	Epinephrine 1 mg/mL	InjectionIntramuscular, Intravenous, Subcutaneous	HF Acquisition Co LLC, DBA HealthFirst	51662-1708	51662-1708-03
epinephrine	Epinephrine 1 mg/mL	Injection, Solution, ConcentrateIntramuscular, Intravenous, Subcutaneous	Baxter Healthcare Corporation	43066-801	43066-0801-02
epinephrine	Epinephrine 1 mg/mL	Injection, Solution, ConcentrateIntramuscular, Intravenous, Subcutaneous	Baxter Healthcare Corporation	43066-803	43066-0803-25
epinephrine	Epinephrine bitartrate 16 ug/mL	Injection, SolutionIntravenous	Baxter Healthcare Corporation	0338-0006	00338-0006-20
epinephrine	Epinephrine .15 mg/.15mL	InjectionSubcutaneous	REMEDYREPACK INC.	70518-4573	70518-4573-00
epinephrine	Epinephrine 1 mg/mL	InjectionIntramuscular, Intravenous, Subcutaneous	GLENMARK PHARMACEUTICALS INC., USA	68462-761	68462-0761-30
Epinephrine	Epinephrine 1 mg/mL	InjectionIntramuscular, Intravenous, Subcutaneous	Amneal Pharmaceuticals Private Limited	80830-1659	80830-1659-02
epinephrine	Epinephrine 1 mg/mL	InjectionIntramuscular, Intravenous, Subcutaneous	Amneal Pharmaceuticals LLC	70121-1660	70121-1660-02

All 76 Epinephrine NDCs

Other NDCs under ANDA 090589

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 090589
Product	Strength	Form · route	Labeler	Product NDC
Epinephrine	Epinephrine .15 mg/.3mL	InjectionIntramuscular, Subcutaneous	A-S Medication Solutions	50090-5254
Epinephrine	Epinephrine .15 mg/.3mL	InjectionIntramuscular, Subcutaneous	Bryant Ranch Prepack	63629-8801
Epinephrine	Epinephrine .3 mg/.3mL	InjectionIntramuscular, Subcutaneous	Redpharm Drug	67296-1946
Epinephrine	Epinephrine .3 mg/.3mL	InjectionIntramuscular, Subcutaneous	REMEDYREPACK INC.	70518-2283
Epinephrine	Epinephrine .3 mg/.3mL	InjectionIntramuscular, Subcutaneous	Asclemed USA, Inc.	76420-188
Epinephrine	Epinephrine .3 mg/.3mL	InjectionIntramuscular, Subcutaneous	Sportpharm LLC	85766-091